封面
市场调查报告书
商品编码
1748740

青光眼手术设备市场-全球产业规模、份额、趋势、机会和预测(按产品、手术方法、最终用途、地区和竞争细分,2020-2030 年)

Glaucoma Surgery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Surgery Method, By End Use, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球青光眼手术设备市场价值为 14.4 亿美元,预计到 2030 年将以 5.14% 的复合年增长率成长。这一增长主要源自于全球青光眼发生率的上升。青光眼是一种慢性眼部疾病,是导致不可逆失明的主要原因之一。随着人们对早期发现和治疗方案认识的提高,人们越来越倾向于手术干预,尤其是对于对药物治疗无反应的患者。根据世界卫生组织 (WHO) 2023 年的报告,全球有超过 22 亿人患有某种形式的视力障碍,凸显了及时的眼部护理和有效治疗的迫切需求。这些趋势凸显了先进手术设备在预防可避免的视力丧失和改善患者生活品质方面发挥越来越大的作用。

市场概览
预测期 2026-2030
2024年市场规模 14.4亿美元
2030年市场规模 19.3亿美元
2025-2030 年复合年增长率 5.14%
成长最快的领域 医院
最大的市场 北美洲

关键市场驱动因素

老年人口不断增加

主要市场挑战

替代治疗方法的可用性

主要市场趋势

微创青光眼手术(MIGS)的优势

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球青光眼手术设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品(打孔器、USC 标记器、USC 规划器、USC 刮鬍刀、镊子、阿尔格刷、探针、钻石刀、青光眼引流装置、雷射系统、其他)
    • 依手术方法(传统青光眼手术、微创青光眼手术、雷射手术)
    • 依最终用途(医院、眼科诊所、其他)
    • 按公司分类(2024)
    • 按地区
  • 市场地图

第六章:北美青光眼手术设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章:欧洲青光眼手术设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太青光眼手术设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章:南美洲青光眼手术设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东和非洲青光眼手术设备市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章: 大环境分析

第 14 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章:竞争格局

  • Alcon, Inc.
  • Abbott Medical Optics Pvt Ltd
  • Asico LLC
  • Katalyst Surgical LLC
  • Ziemer Ophthalmic Systems AG
  • Lumenis Ltd
  • Iridex Corporation
  • Carl Zeiss Meditec AG
  • Allergan Plc.
  • Glaukos Corporation

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 16180

The Global Glaucoma Surgery Devices Market was valued at USD 1.44 billion in 2024 and is anticipated to grow at a CAGR of 5.14% through 2030. This growth is primarily driven by the rising global incidence of glaucoma, a chronic eye disease that is among the leading causes of irreversible blindness. With increased awareness of early detection and treatment options, there is a growing preference for surgical interventions, particularly for patients who do not respond to medications. According to the World Health Organization (WHO) 2023 report, more than 2.2 billion people suffer from some form of vision impairment globally, underscoring the critical need for timely eye care and effective treatments. These trends highlight the expanding role of advanced surgical devices in preventing avoidable vision loss and improving quality of life for affected individuals.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.44 Billion
Market Size 2030USD 1.93 Billion
CAGR 2025-20305.14%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Key Market Drivers

Increasing Geriatric Population

The expanding global geriatric population is a major driver of the Global Glaucoma Surgery Devices Market. According to WHO, the proportion of people aged 65 and above rose from 5.5% in 1974 to 10.3% in 2024 and is projected to reach 20.7% by 2074. Since glaucoma predominantly affects older adults, the growing elderly demographic is directly linked to an increased prevalence of this condition. As life expectancy continues to rise, so does the number of individuals at risk for glaucoma, intensifying the need for early diagnosis and surgical intervention. Additionally, aging populations in both developed and emerging markets are experiencing higher healthcare access, resulting in more frequent eye screenings and subsequent treatments. Innovations in surgical techniques, particularly the rise of micro-invasive glaucoma surgery (MIGS), are also enabling safer, more effective solutions tailored to elderly patients. As this population segment expands, demand for reliable glaucoma surgery devices is expected to remain strong.

Key Market Challenges

Availability of Alternative Treatment Methods

The presence of alternative treatment methods presents a notable challenge to the growth of the Global Glaucoma Surgery Devices Market. Non-surgical interventions-particularly pharmaceutical eye drops-remain widely used due to their non-invasive nature and patient familiarity. Laser therapies, such as selective laser trabeculoplasty (SLT) and laser peripheral iridotomy (LPI), offer additional less-invasive options with shorter recovery periods, making them appealing to many patients. Furthermore, minimally invasive glaucoma surgery (MIGS) blurs the line between medical and surgical treatments, offering safer procedures that can be performed alongside cataract surgeries. These alternatives often serve as the first line of treatment, especially in early-stage cases, limiting the number of patients opting for traditional surgical devices. Factors such as patient age, comorbidities, and treatment affordability further influence the decision, often leading healthcare professionals to recommend less invasive measures initially.

Key Market Trends

Minimally Invasive Glaucoma Surgery (MIGS) Dominance

The rising adoption of Minimally Invasive Glaucoma Surgery (MIGS) is a pivotal trend reshaping the Global Glaucoma Surgery Devices Market. MIGS procedures are gaining popularity due to their less invasive approach, which involves smaller incisions, faster recovery, and reduced postoperative risks. This approach enhances patient outcomes and satisfaction, particularly among older individuals. Additionally, MIGS techniques are frequently performed alongside cataract surgery, offering a dual-benefit solution that is efficient and convenient for patients and providers. With a strong safety profile and effective intraocular pressure (IOP) reduction, MIGS has become an attractive option for managing both early and moderate stages of glaucoma. The growing preference for such procedures is prompting manufacturers to innovate and expand their MIGS device portfolios, solidifying its dominance within the surgical treatment landscape.

Key Market Players

  • Alcon, Inc.
  • Abbott Medical Optics Pvt Ltd
  • Asico LLC
  • Katalyst Surgical LLC
  • Ziemer Ophthalmic Systems AG
  • Lumenis Ltd
  • Iridex Corporation
  • Carl Zeiss Meditec AG
  • Allergan Plc.
  • Glaukos Corporation

Report Scope:

In this report, the Global Glaucoma Surgery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Glaucoma Surgery Devices Market, By Product:

  • Punches, USC marker, USC planner, USC shaver, Forceps, Algerbrush, Probes
  • Diamond knives
  • Glaucoma Drainage Device
  • Laser System
  • Others

Glaucoma Surgery Devices Market, By Surgery Method:

  • Traditional glaucoma surgery
  • Minimal invasive glaucoma surgery
  • Laser surgery

Glaucoma Surgery Devices Market, By End Use:

  • Hospitals
  • Ophthalmic clinics
  • Others

Glaucoma Surgery Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Glaucoma Surgery Devices Market.

Available Customizations:

Global Glaucoma Surgery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customers

5. Global Glaucoma Surgery Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Punches, USC marker, USC planner, USC shaver, forceps, algerbrush, probes, diamond knives, Glaucoma Drainage Device, Laser System, Others)
    • 5.2.2. By Surgery Method (Traditional glaucoma surgery, Minimal invasive glaucoma surgery, Laser surgery)
      • 5.2.2.1. By Traditional glaucoma surgery (Trabeculectomy, Tube shunt surgery)
      • 5.2.2.2. By Minimal invasive glaucoma surgery (Trabecular meshwork bypass, Suprachoroidal space implants, Subconjunctival space implants)
      • 5.2.2.3. By Laser surgery (Trabeculoplasty, Iridotomy, Cyclophotocoagulation)
    • 5.2.3. By End Use (Hospitals, Ophthalmic clinics, Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Glaucoma Surgery Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Surgery Method
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Glaucoma Surgery Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Surgery Method
        • 6.3.1.2.3. By End Use
    • 6.3.2. Mexico Glaucoma Surgery Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Surgery Method
        • 6.3.2.2.3. By End Use
    • 6.3.3. Canada Glaucoma Surgery Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Surgery Method
        • 6.3.3.2.3. By End Use

7. Europe Glaucoma Surgery Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Surgery Method
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Glaucoma Surgery Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Surgery Method
        • 7.3.1.2.3. By End Use
    • 7.3.2. Germany Glaucoma Surgery Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Surgery Method
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Glaucoma Surgery Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Surgery Method
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Glaucoma Surgery Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Surgery Method
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Glaucoma Surgery Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Surgery Method
        • 7.3.5.2.3. By End Use

8. Asia-Pacific Glaucoma Surgery Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Surgery Method
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Glaucoma Surgery Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Surgery Method
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Glaucoma Surgery Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Surgery Method
        • 8.3.2.2.3. By End Use
    • 8.3.3. South Korea Glaucoma Surgery Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Surgery Method
        • 8.3.3.2.3. By End Use
    • 8.3.4. Japan Glaucoma Surgery Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Surgery Method
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Glaucoma Surgery Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Surgery Method
        • 8.3.5.2.3. By End Use

9. South America Glaucoma Surgery Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Surgery Method
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Glaucoma Surgery Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Surgery Method
        • 9.3.1.2.3. By End Use
    • 9.3.2. Argentina Glaucoma Surgery Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Surgery Method
        • 9.3.2.2.3. By End Use
    • 9.3.3. Colombia Glaucoma Surgery Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Surgery Method
        • 9.3.3.2.3. By End Use

10. Middle East and Africa Glaucoma Surgery Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Surgery Method
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Glaucoma Surgery Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Surgery Method
        • 10.3.1.2.3. By End Use
    • 10.3.2. Saudi Arabia Glaucoma Surgery Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Surgery Method
        • 10.3.2.2.3. By End Use
    • 10.3.3. UAE Glaucoma Surgery Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Surgery Method
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Alcon, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Product & Services
    • 15.1.4. Financials (In case of listed companies)
    • 15.1.5. Recent Developments
    • 15.1.6. SWOT Analysis
  • 15.2. Abbott Medical Optics Pvt Ltd
  • 15.3. Asico LLC
  • 15.4. Katalyst Surgical LLC
  • 15.5. Ziemer Ophthalmic Systems AG
  • 15.6. Lumenis Ltd
  • 15.7. Iridex Corporation
  • 15.8. Carl Zeiss Meditec AG
  • 15.9. Allergan Plc.
  • 15.10. Glaukos Corporation

16. Strategic Recommendations

17. About Us & Disclaimer